STAGE IV PANCREATIC CANCER AJCC V8
Clinical trials for STAGE IV PANCREATIC CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IV PANCREATIC CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IV PANCREATIC CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo tackles tough pancreatic cancer in early trial
Disease control CompletedThis early-phase study tested two drugs—binimetinib and hydroxychloroquine—in 34 people with advanced pancreatic cancer that has a specific gene change (KRAS mutation). The goal was to find the safest dose of hydroxychloroquine when used with binimetinib, and to see if the combin…
Matched conditions: STAGE IV PANCREATIC CANCER AJCC V8
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 01, 2026 16:01 UTC
-
Vitamin d and malaria drug join forces against pancreatic cancer
Disease control CompletedThis study tested whether adding two drugs—paricalcitol (a form of vitamin D) and hydroxychloroquine (a malaria drug)—to standard chemotherapy could help shrink tumors in people with advanced pancreatic cancer that has spread. Ten participants received the combination treatment. …
Matched conditions: STAGE IV PANCREATIC CANCER AJCC V8
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated Apr 30, 2026 15:48 UTC
-
Weight-Loss drug shows promise for pancreatic cancer patients
Symptom relief CompletedThis study tested a drug called telotristat ethyl in 23 people with advanced pancreatic cancer who had lost at least 10% of their body weight. The goal was to see if the drug could help them stabilize or gain weight, which might make chemotherapy easier to tolerate and improve su…
Matched conditions: STAGE IV PANCREATIC CANCER AJCC V8
Phase: PHASE2 • Sponsor: Emory University • Aim: Symptom relief
Last updated May 01, 2026 15:58 UTC